ES8303295A1 - Procedimiento para la obtencion de derivados de 3-amino-1,2-propandiol - Google Patents

Procedimiento para la obtencion de derivados de 3-amino-1,2-propandiol

Info

Publication number
ES8303295A1
ES8303295A1 ES495881A ES495881A ES8303295A1 ES 8303295 A1 ES8303295 A1 ES 8303295A1 ES 495881 A ES495881 A ES 495881A ES 495881 A ES495881 A ES 495881A ES 8303295 A1 ES8303295 A1 ES 8303295A1
Authority
ES
Spain
Prior art keywords
lower alkylene
alkylene
amino
preparation
aza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES495881A
Other languages
English (en)
Other versions
ES495881A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES8303295A1 publication Critical patent/ES8303295A1/es
Publication of ES495881A0 publication Critical patent/ES495881A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C265/00—Derivatives of isocyanic acid
    • C07C265/12—Derivatives of isocyanic acid having isocyanate groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C07D303/26—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds having one or more free hydroxyl radicals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2571/00—Bundles of articles held together by packaging elements for convenience of storage or transport, e.g. portable segregating carrier for plural receptacles such as beer cans, pop bottles; Bales of material
    • B65D2571/00006—Palletisable loads, i.e. loads intended to be transported by means of a fork-lift truck
    • B65D2571/00012—Bundles surrounded by a film
    • B65D2571/00018—Bundles surrounded by a film under tension

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE 3-AMINO-1,2-PROPANDIOL, DE FORMULA (I), EN LA QUE AR, ALK, R Q Y R PUEDEN SER VARIOS TIPOS DE RADICALES; Y N VALE 0 O 1. CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA HNR R , EN LAS QUE AR ES AR O UN RESTO AR SUSTITUIDO POR UNO O DOS GRUPOS TRANSFORMABLES EN HIDROXI POR AMINOLISIS; X PUEDE SER VARIOS RADICALES; Y N, ALK, R Y R TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE LLEVA A CABO EN UN DISOLVENTE INERTE TAL COMO DIOXANO A TEMPERATURAS COMPRENDIDAS ENTRE -10 C Y 50 C. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE LA ANGINA DE PECHO E IRREGULARIDADES EN EL RITMO CARDIACO, ASI COMO PARA REDUCIR LA PRESION SANGUINEA.
ES495881A 1979-03-01 1980-10-13 Procedimiento para la obtencion de derivados de 3-amino-1,2-propandiol Granted ES495881A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH203779 1979-03-01

Publications (2)

Publication Number Publication Date
ES8303295A1 true ES8303295A1 (es) 1983-02-01
ES495881A0 ES495881A0 (es) 1983-02-01

Family

ID=4224451

Family Applications (5)

Application Number Title Priority Date Filing Date
ES489031A Expired ES8103728A1 (es) 1979-03-01 1980-02-28 Procedimiento para la obtencion de derivados del 3-amino-1,2propandiol
ES495882A Granted ES495882A0 (es) 1979-03-01 1980-10-13 Procedimiento para la obtencion de derivados de 3-amino-1,2-propandiol
ES495881A Granted ES495881A0 (es) 1979-03-01 1980-10-13 Procedimiento para la obtencion de derivados de 3-amino-1,2-propandiol
ES495879A Expired ES8107153A1 (es) 1979-03-01 1980-10-13 Procedimiento para la obtencion de derivados de 3-amino-1,2-propandiol
ES495880A Expired ES8205749A1 (es) 1979-03-01 1980-10-13 Procedimiento para la obtencion de derivados de 3-amino-1,2-propandiol

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES489031A Expired ES8103728A1 (es) 1979-03-01 1980-02-28 Procedimiento para la obtencion de derivados del 3-amino-1,2propandiol
ES495882A Granted ES495882A0 (es) 1979-03-01 1980-10-13 Procedimiento para la obtencion de derivados de 3-amino-1,2-propandiol

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES495879A Expired ES8107153A1 (es) 1979-03-01 1980-10-13 Procedimiento para la obtencion de derivados de 3-amino-1,2-propandiol
ES495880A Expired ES8205749A1 (es) 1979-03-01 1980-10-13 Procedimiento para la obtencion de derivados de 3-amino-1,2-propandiol

Country Status (22)

Country Link
US (3) US4497813A (es)
EP (1) EP0015505B1 (es)
JP (1) JPS55167263A (es)
KR (4) KR850000023B1 (es)
AT (1) ATE8876T1 (es)
AU (1) AU540060B2 (es)
CA (1) CA1134843A (es)
DD (1) DD150456A5 (es)
DE (1) DE3068839D1 (es)
DK (1) DK153940C (es)
ES (5) ES8103728A1 (es)
FI (1) FI800582A (es)
GR (1) GR66666B (es)
HU (1) HU181697B (es)
IE (1) IE49530B1 (es)
IL (1) IL59487A (es)
MY (1) MY8700552A (es)
NO (1) NO151743C (es)
NZ (1) NZ193012A (es)
PL (1) PL222358A1 (es)
PT (1) PT70885A (es)
ZA (1) ZA801165B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3718342A (en) * 1970-11-13 1973-02-27 R Freed Amusement vehicle
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
JPS5726653A (en) * 1980-05-09 1982-02-12 Ciba Geigy Ag Substituted phenyl ether
US4410548A (en) * 1980-07-09 1983-10-18 Reckitt & Colman Products Limited Propanolamine derivatives
GR74992B (es) * 1980-08-13 1984-07-12 Ciba Geigy Ag
US4657929A (en) * 1983-10-25 1987-04-14 Fisons Plc Compounds
GB8420837D0 (en) * 1984-08-16 1984-09-19 Beecham Group Plc Compounds
JPS6341451A (ja) * 1986-08-06 1988-02-22 Nippon Kayaku Co Ltd エ−テル誘導体およびそれを有効成分とする殺ダニ、殺虫組成物
US4897880A (en) * 1987-02-17 1990-01-30 Soricon Corporation Data acquisition control method and system for a hand held reader
GB8801306D0 (en) * 1988-01-21 1988-02-17 Ici Plc Chemical compounds
US4906634A (en) * 1988-03-08 1990-03-06 Schering A.G. Novel N-[4-(aminosubstituted)phenyl]methanesulfonamides and their use as cardiovascular agents
EP0355583B1 (en) * 1988-08-10 1995-01-25 Otsuka Pharmaceutical Co., Ltd. Cardiotonics
US5198448A (en) * 1988-08-10 1993-03-30 Otsuka Pharmaceutical Company, Limited Cardiotonics
GB8925032D0 (en) * 1989-11-06 1989-12-28 Ici Plc Chemical compounds
US5232948A (en) * 1990-09-10 1993-08-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
DE69233586T2 (de) * 1991-08-23 2006-09-28 NPS Pharmaceuticals, Inc., Salt Lake City Kalzium-Rezeptor aktive Verbindungen
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
AU7532294A (en) * 1993-07-31 1995-02-28 Smithkline Beecham Plc 2-benzoheterocyclyloxy or thiopropanolamine derivatives with adreno receptor agonist activity
EP0787122B9 (en) 1994-10-21 2007-10-17 Nps Pharmaceuticals, Inc. Calcium receptor-active compounds
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
AU737724B2 (en) * 1995-10-10 2001-08-30 William John Louis 3-amino-propoxyphenyl derivatives (I)
ES2326004T3 (es) 1996-05-01 2009-09-28 Nps Pharmaceuticals, Inc. Compuestos activos de receptor de ion inorganico.
EP0827746B1 (en) 1996-09-05 2002-04-03 Eli Lilly And Company Carbazole analogues as selective beta3 adrenergic agonists
US5808080A (en) 1996-09-05 1998-09-15 Eli Lilly And Company Selective β3 adrenergic agonists
CO5011072A1 (es) 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
AP2006003700A0 (en) 2004-02-13 2006-08-31 Warner Lambert Co Androgen receptor modulators
EP1737813A1 (en) 2004-04-13 2007-01-03 Warner-Lambert Company LLC Androgen modulators
EP1740533A1 (en) 2004-04-22 2007-01-10 Warner-Lambert Company LLC Androgen modulators
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
CA2646133A1 (en) * 2006-04-21 2007-11-01 Zach System S.P.A. Process for preparing dorzolamide
CA2704199C (en) * 2007-11-01 2016-01-19 Acucela Inc. Amine derivative compounds for treating ophthalmic diseases and disorders
WO2012004549A1 (en) 2010-07-05 2012-01-12 The University Of Nottingham Phenoxypropanol derivatives and their use in treating cardiac and cardiovascular diseases
WO2015106164A1 (en) * 2014-01-10 2015-07-16 Rgenix, Inc. Lxr agonists and uses thereof
KR20190017795A (ko) * 2016-05-13 2019-02-20 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 아드레날린 수용체 조절 화합물 및 이의 사용 방법
WO2019104062A1 (en) 2017-11-21 2019-05-31 Rgenix, Inc. Polymorphs and uses thereof
CN109369556A (zh) * 2018-10-19 2019-02-22 格斯雅汇(天津)有限公司 一种5-n,n-二苄胺乙酰水杨酰胺的合成方法
EP4073025B1 (en) 2019-12-13 2024-03-27 Inspirna, Inc. Metal salts and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE368197B (es) * 1968-11-18 1974-06-24 Pfizer
JPS4947330A (es) * 1972-08-31 1974-05-08
JPS4975547A (es) * 1972-08-31 1974-07-20
GB1398738A (en) * 1972-12-05 1975-06-25 Pfizer Ltd Propanolamine derivatives
AR208397A1 (es) * 1973-02-20 1976-12-27 Ciba Geigy Ag Procedimiento para la elaboracion de compuestos de 1-piridiloxi-2-hidroxi-3-amino-propano1-piraziniloxi-2-hidroxi-3-amino-propano y 1-pirimidiniloxi-2-hidroxi-3-amino-propan
GB1435276A (en) * 1974-04-10 1976-05-12 Pfizer Ltd Oxazolidines and conversion to propanolamines
US4165384A (en) * 1974-11-01 1979-08-21 Aktiebolaget Hassle Amide substituted phenoxy propanol amines
ZA754241B (en) * 1974-11-01 1976-06-30 Haessle Ab New amines
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH624395A5 (es) * 1976-01-08 1981-07-31 Ciba Geigy Ag
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
SE416545B (sv) * 1976-10-07 1981-01-19 Haessle Ab Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat
DE2905877A1 (de) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols

Also Published As

Publication number Publication date
AU540060B2 (en) 1984-11-01
JPS55167263A (en) 1980-12-26
IL59487A (en) 1983-05-15
IE800413L (en) 1980-09-01
CA1134843A (en) 1982-11-02
NZ193012A (en) 1981-11-19
ES495879A0 (es) 1981-10-01
DK153940B (da) 1988-09-26
NO151743C (no) 1985-05-29
DE3068839D1 (en) 1984-09-13
ES489031A0 (es) 1981-02-16
ES8106880A1 (es) 1981-09-16
DD150456A5 (de) 1981-09-02
FI800582A (fi) 1980-09-02
KR840005306A (ko) 1984-11-05
DK153940C (da) 1989-05-22
ES495881A0 (es) 1983-02-01
EP0015505B1 (de) 1984-08-08
IL59487A0 (en) 1980-05-30
DK87880A (da) 1980-09-02
GR66666B (es) 1981-04-07
EP0015505A1 (de) 1980-09-17
KR850000023B1 (ko) 1985-02-11
NO151743B (no) 1985-02-18
MY8700552A (en) 1987-12-31
KR830001864A (ko) 1983-05-19
ES8107153A1 (es) 1981-10-01
PT70885A (de) 1980-03-01
ZA801165B (en) 1981-02-25
KR850000020B1 (ko) 1985-02-11
ES495882A0 (es) 1981-09-16
ES495880A0 (es) 1982-08-01
KR840005304A (ko) 1984-11-05
ES8103728A1 (es) 1981-02-16
HU181697B (en) 1983-11-28
KR850000022B1 (ko) 1985-02-11
PL222358A1 (es) 1980-12-15
AU5602280A (en) 1980-09-04
IE49530B1 (en) 1985-10-16
US4636511A (en) 1987-01-13
ES8205749A1 (es) 1982-08-01
ATE8876T1 (de) 1984-08-15
US4497813A (en) 1985-02-05
KR840005305A (ko) 1984-11-05
NO800586L (no) 1980-09-02
KR850000021B1 (ko) 1985-02-04
US4727067A (en) 1988-02-23

Similar Documents

Publication Publication Date Title
ES8106880A1 (es) Procedimiento para la obtencion de derivados de 3-amino-1,2-propandiol
ATE79376T1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE37719T1 (de) Sulphenamide, verfahren zur herstellung von diesen verbindungen und verwendung von obengenannten verbindungen zur herstellung von pharmazeutischen praeparaten.
ES8203883A1 (es) Un procedimiento para la preparacion de derivados de imida- zol
IL62806A (en) Substituted phenyl ethers,their manufacture and pharmaceutical compositions containing them
DK183789D0 (da) 2-alkyl-3-benzoylbenzofuraner og laegemidler indeholdende disse
JPS55118488A (en) Theobromine derivative and its preparation
ES8205192A1 (es) Procedimiento para la obtencion de derivados de 2-amino-eta-nol
SE7905051L (sv) Nya sulfonamider
ES8403130A1 (es) Procedimiento para la preparacion de tienobenzodiazepinonas sustituidas.
ES8106714A1 (es) Procedimiento de preparar derivados 1,2,4-oxadiacinicos